Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Language
Publication year range
1.
J Am Coll Cardiol ; 84(7): 663-674, 2024 Aug 13.
Article in English | MEDLINE | ID: mdl-39111974

ABSTRACT

Industrially produced trans fat (iTFA) is a harmful compound created as a substitute for animal and saturated fats. Estimated to cause up to 500,000 deaths per year, it is replaceable. In 2018, Resolve to Save Lives, the World Health Organization (WHO), Global Health Advocacy Incubator, and NCD Alliance partnered to achieve global trans fat elimination. The WHO Director-General called for the elimination of trans fat by 2023 through best practice policies outlined in the WHO REPLACE package. Since the accelerated global efforts in 2018, 43 countries have adopted best practice regulations protecting an additional 3.2 billion people and building momentum toward global elimination. Current coverage will prevent 66% of deaths estimated to be caused each year by trans fat in foods. Despite producing and selling iTFA-free products in many countries, companies continue to sell iTFA-containing products in unregulated markets. Global incentives, accountability mechanisms, and regional policies will help achieve the elimination goal.


Subject(s)
Global Health , Noncommunicable Diseases , Trans Fatty Acids , Humans , Trans Fatty Acids/adverse effects , Noncommunicable Diseases/prevention & control , Noncommunicable Diseases/epidemiology , Risk Factors , World Health Organization
SELECTION OF CITATIONS
SEARCH DETAIL